UB Study: Oral Therapy Reduces Speed, Severity of Polyp Formation

Updated October 22, 2014 This content is archived.

The bioactive protein interleukin-10 successfully treats chronic, precancerous intestinal inflammation, according to a UB animal study featured on the cover of Cancer Research and led by Allen Y. Chung, a student in the Medical Scientist Training (MD/PhD) Program.